Navalign LLC
ABBV icon

Navalign LLC’s AbbVie ABBV Stock Holding History

Navalign LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$532K Sell
2,033
-311
-13% -$79.7K 0.12% 87
2026
Q2 		$590K Sell
2,344
-7
-0.3% -$1.51K 0.14% 87
2026
Q1 		$511K Sell
2,351
-175
-7% -$38.8K 0.13% 88
2025
Q4 		$577K Sell
2,526
-111
-4% -$25.3K 0.14% 86
2025
Q3 		$611K Sell
2,637
-24
-0.9% -$4.89K 0.16% 83
2025
Q2 		$494K Sell
2,661
-98
-4% -$18.2K 0.14% 85
2025
Q1 		$578K Buy
2,759
+71
+3% +$13.8K 0.16% 82
2024
Q4 		$478K Buy
2,688
+2
+0.1% +$368 0.14% 90
2024
Q3 		$531K Buy
2,686
+1
+0% +$187 0.16% 87
2024
Q2 		$461K Sell
2,685
-108
-4% -$17.9K 0.15% 90
2024
Q1 		$509K Sell
2,793
-47
-2% -$8.1K 0.17% 88
2023
Q4 		$440K Buy
2,840
+150
+6% +$21.9K 0.15% 98
2023
Q3 		$401K Buy
2,690
+39
+1% +$5.72K 0.15% 104
2023
Q2 		$357K Buy
2,651
+30
+1% +$4.4K 0.14% 90
2023
Q1 		$418K Buy
2,621
+2
+0.1% +$306 0.17% 89
2022
Q4 		$423K Sell
2,619
-16
-0.6% -$2.45K 0.17% 100
2022
Q3 		$354K Hold
2,635
– – 0.16% 97
2022
Q2 		$404K Hold
2,635
– – 0.18% 90
2022
Q1 		$415K Buy
2,635
+46
+2% +$6.68K 0.18% 95
2021
Q4 		$351K Hold
2,589
– – 0.14% 105
2021
Q3 		$279K Hold
2,589
– – 0.12% 108
2021
Q2 		$292K Buy
2,589
+2
+0.1% +$225 0.12% 110
2021
Q1 		$280K Buy
+2,587
New +$277K 0.12% 113

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Navalign LLC's ABBV Position: Q3 2026 in Review

Navalign LLC reduced its AbbVie (ABBV) stake by 13% in Q3 2026, selling an estimated $79.7K and leaving 2,033 shares worth $532K. The position accounts for 0.12% of the portfolio, ranked #87.

Navalign LLC first reported a position in ABBV in Q1 2021 and has held it in 23 quarters since. The position peaked at $611K in Q3 2025. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Navalign LLC held 2,033 shares of AbbVie worth $532K as of Q3 2026.
  • Navalign LLC sold 311 AbbVie shares in Q3 2026, an estimated $79.7K.
  • AbbVie made up 0.12% of Navalign LLC's portfolio in Q3 2026, its #87 holding.
  • Navalign LLC first reported a position in AbbVie in Q1 2021 and has held it in 23 quarters since.
  • Navalign LLC's AbbVie position peaked at $611K in Q3 2025.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Navalign LLC's 13F filing for Q3 2026, filed 9 Nov 2026.